ACADIA Pharmaceuticals Inc (NAS:ACAD)
$ 16.32 0.37 (2.32%) Market Cap: 2.71 Bil Enterprise Value: 2.20 Bil PE Ratio: 90.67 PB Ratio: 5.23 GF Score: 74/100

ACADIA Pharmaceuticals Inc Annual Shareholders Meeting Transcript

Jun 23, 2020 / 03:00PM GMT
Release Date Price: $52.73 (+0.78%)
Operator

Hello, and welcome to the Annual Meeting of Stockholders of ACADIA Pharmaceuticals Inc.

Please note that today's meeting is being recorded.

It is now my pleasure to turn today's meeting over to Steve Biggar, Chairman of the Board of Directors of ACADIA Pharmaceuticals. Mr. Biggar, the floor is yours.

Stephen R. Biggar
ACADIA Pharmaceuticals Inc. - Independent Chairman of the Board

Good morning, everyone. My name is Steve Biggar, and I'm the Chairman of the Board of Directors of ACADIA Pharmaceuticals. I'd like to welcome you to the 2020 Annual Meeting of Stockholders, which is being [conducted] virtually for the first time this year, obviously, due to the COVID-19 pandemic. I very much hope that all of you are healthy and safe in these extraordinarily difficult times for our country and for the world.

Before I call the meeting to order, I'd like to introduce you to the other members of the Board and our executive officers who are with us today. The other members of the Board present today are: Steve Davis, who is also our Chief

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot